Shlomo Yanai
Director · Amneal Pharmaceuticals, Inc.
Individual
- 2026
- May 8, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Shlomo Yanai files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jacek Olczak - $14.57M in PM purchases and sales in the last 12 months
- Emmanuel Babeau - $6.14M in PM purchases and sales in the last 12 months
- Nikita Shah - $4.14M in AMRX purchases and sales in the last 12 months
- Jason B. Daly - $3.77M in AMRX purchases and sales in the last 12 months
- Wilde Frederic de - $3.65M in PM purchases and sales in the last 12 months
- Stacey Kennedy - $2.63M in PM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Shlomo Yanai?
Shlomo Yanai is a corporate insider, tracked as Director of Amneal Pharmaceuticals, Inc. (AMRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Shlomo Yanai last file a Form 4?
The most recent primary Form 4 on record is dated 8 May 2026, one of 2 filings going back to 2026.
